Price Band of ₹155/– ₹165/- per Equity Share bearing face value of ₹10/- each (“Equity Shares”)
Bid/Offer Opening Date – Wednesday, September 10, 2025 and Bid/Offer Closing Date – Friday, September 12, 2025.
Minimum Bid Lot is 90 Equity Shares and in multiples of 90 Equity Shares thereafter.
RISKS TO INVESTORS
Mumbai, September 3, 2025: Shringar House of Mangalsutra Limited has fixed the price band of ₹155/- to ₹165/- per Equity Share of face value ₹10/- each for its maiden initial public offer.
The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Wednesday, September 10, 2025, for subscription and close on Friday, September 12, 2025. Investors can bid for a minimum of 90 Equity Shares and in multiples of 90 Equity Shares thereafter.
The IPO is entirely a fresh issue of shares up to 2,43,00,000 equity shares with no offer for sale component.
Incorporated in the year 2009, Shringar House of Mangalsutra is engaged in designing, manufacturing, and marketing a diverse range of Mangalsutras adorned with various stones such as American diamonds, cubic zirconia, pearls, mother of pearl, and semi-precious stones, crafted in 18k and 22k gold. The company primarily serves its business-to-business (B2B) clients and holds approximately 6% of the organized Mangalsutra market in India as of CY23, according to a CareEdge Report.
Shringar House of Mangalsutra caters to a wide array of clients, including Corporate Clients, wholesale jewellers, and retailers across 24 states and 4 union territories in India. Beyond its domestic market, the company has expanded its presence internationally, serving clients in the UK, New Zealand, the UAE, the USA, and the Republic of Fiji. Its marquee Corporate Clients include Malabar Gold Limited, Titan Company Limited, GRT Jewellers India Private Limited, Reliance Retail Limited, Novel Jewels Limited (Aditya Birla Group), Joyalukkas India Limited, and international names like Goldbox Enterprises Limited (UK), Sona Sansaar Limited (New Zealand), and Damas Jewellery LLC (UAE). As on March 31, 2025, the company served 34 corporate clients, 1089 wholesalers, and 81 retailers.
In addition to its core business, Shringar House of Mangalsutra also manufacture and supply Mangalsutras on a job-work basis to their Corporate Clients. For the Fiscals 2025, 2024, and 2023, The company processed a total of 1,320.72 kgs, 1,221.19 kgs and 870.26 kgs of bullion into Mangalsutras.
The company has an extensive portfolio of Mangalsutras, featuring over 15 collections and more than 10,000 active SKUs, offering designs for special occasions like weddings, festivals, and anniversaries, as well as everyday wear. Its collections include antique, bridal, traditional, contemporary, and Indo-western styles, catering to women of all ages with varying price points and weights.
As of June 30, 2025, Shringar House of Mangalsutra employed a dedicated in-house design team of 22 full-time employees focused on creating innovative designs that reflect the latest trends, customer preferences, and demographic needs. Additionally, the company works with 166 in-house Karigars (artisans) and collaborates with a network of third-party Karigars to meet the growing demand for its products.
The company’s registered office is located at Mumbai's Kalbadevi Road and manufacturing facility is located at Lower Parel (West), Mumbai.
Shringar House of Mangalsutra’s revenue from operations increased to ₹ 1,429.81 crore in Fiscal 2025 from ₹ 1,101.52 crore in Fiscal 2024. Profit after tax increased from ₹ 31.10 crore in Fiscal 2024 to ₹ 61.11 crore in Fiscal 2025.
Choice Capital Advisors Private Limited is the sole book-running lead manager, and MUFG Intime India Private Limited is the registrar of the issue.
The Issue is being made through the book-building process, wherein not more than 50% of the net issue shall be available for allocation on a proportionate basis to qualified institutional buyers, not less than 15% of the net issue shall be available for allocation to non-institutional bidders, and not less than 35% of the net issue shall be available for allocation to retail individual bidders.
DISCLAIMERS: SHRINGAR HOUSE OF MANGALSUTRA LIMITED is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed a red herring prospectus dated September 01, 2025 with the RoC. The RHP is made available on the website of the SEBI at www.sebi.gov.in as well as on the website of the BRLM i.e., Choice Capital Advisors Private Limited at www.choiceindia.com/merchant-investment-banking, the website of the NSE at www.nseindia.com and the website of the BSE at www.bseindia.com and the website of the Company at www.shringar.ms. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, please see the section “Risk Factors” beginning on page 33 of the RHP. Potential investors should not rely on the DRHP for making any investment decision but should only rely on the information included in the RHP filed by the Company with the RoC. The Equity Shares offered in the Issue have not been, and will not be, registered under the U.S. Securities Act and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. The Equity Shares offered in the issue are being offered and sold only outside the United States in “offshore transactions” as defined in and in reliance on Regulation S under the U.S. Securities Act (“Regulation S”).
DISCLAIMER CLAUSE OF SEBI: SEBI only gives its observations on the offer documents and this does not constitute approval of either the Issue or the specified securities stated in the Offer Documents. The investors are advised to refer to page 340 of the RHP for the full text of the disclaimer clause of SEBI.
DISCLAIMER CLAUSE OF BSE: It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the RHP has been cleared or approved by BSE Limited nor does it certify the correctness or completeness of any of the contents of the RHP. The investors are advised to refer to the page 343 of the RHP for the full text of the disclaimer clause of BSE.
DISCLAIMER CLAUSE OF NSE (The Designated Stock Exchange): It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Offer Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Issue Document. The investors are advised to refer to page 343 of the RHP for the full text of the disclaimer clause of NSE.
No comments:
Post a Comment